false --09-30 0001140859 0001140859 2024-03-12 2024-03-12 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 

 

 

FORM 8-K 

 

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): March 12, 2024

 

 

 

Cencora, Inc.

(Exact name of registrant as specified in its charter)

 

 

 

Commission File Number: 1-6671

 

Delaware   23-3079390

(State or other jurisdiction of

 

(I.R.S. Employer

incorporation or organization)   Identification No.)
     

1 West First Avenue  Conshohocken   PA

 

19428-1800

(Address of principal executive offices)

 

(Zip Code)

 

(610) 727-7000

(Registrant’s telephone number, including area code) 

 

Not Applicable

(Former name or former address, if changed since last report.)

 

 Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class Trading Symbol(s) Name of exchange on which registered
Common stock COR New York Stock Exchange (NYSE)

 

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ¨

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

 

 

 

 

 

Item 5.03 Amendment to Articles of Incorporation or Bylaws

 

As described under Item 5.07 of this Current Report on Form 8-K, at the 2024 Annual Meeting of Shareholders (the “Annual Meeting”) of Cencora, Inc. (the “Company”) held on March 12, 2024, the shareholders of the Company approved proposed amendments (the “Amendments”) to the Company’s certificate of incorporation to permit the exculpation of officers, as is consistent with the Delaware General Corporation Law, and to effect other miscellaneous clarifications and changes. The Amendments are described in detail under “Item 4: Approval of an amendment of the certificate of incorporation to provide for the exculpation of officers as permitted by Delaware law” and “Item 5: Approval of miscellaneous amendments to the certificate of incorporation” commencing on pages 84 and 86, respectively, of the Company’s definitive proxy statement filed with the Securities and Exchange Commission on January 29, 2024 (the “Proxy Statement”) in connection with the Annual Meeting. The foregoing description of the Amendments does not purport to be complete and is qualified in its entirety by reference to the full text of the certificate of incorporation, as modified by the Amendments (the “Amended and Restated Certificate of Incorporation”), which is filed as Exhibit 3.1 to this Current Report on Form 8-K and incorporated herein by reference. The Amended and Restated Certificate of Incorporation became effective upon its filing with the Secretary of State of the State of Delaware on March 14, 2024.

 

Item 5.07. Submission of Matters to a Vote of Security Holders.

 

(a)The Company held its Annual Meeting on March 12, 2024.

 

(b)Each of the five items listed below was submitted to a vote of the Company’s shareholders at the Annual Meeting and is described in more detail in the Proxy Statement. The final voting results are set forth below:

 

Item 1 - Election of Directors.

 

Each of the individuals listed below was elected by the Company’s shareholders to serve as a director until the 2025 Annual Meeting of Shareholders and until his or her successor is duly elected and qualified.

 

Nominees  For  Against  Abstentions  Broker Non-Votes
Ornella Barra  173,871,076  1,659,203  181,183  8,997,321
Werner Baumann  175,342,892  214,974  153,596  8,997,321
Steven H. Collis  167,609,243  7,068,961  1,033,258  8,997,321
D. Mark Durcan  175,224,736  335,132  151,594  8,997,321
Richard W. Gochnauer  169,926,452  5,609,416  175,594  8,997,321
Lon R. Greenberg  170,454,959  5,111,897  144,606  8,997,321
Kathleen W. Hyle  171,180,797  4,382,477  148,188  8,997,321
Lorence H. Kim, M.D.  173,913,409  1,645,766  152,287  8,997,321
Redonda G. Miller, M.D.  169,240,543  6,332,365  138,554  8,997,321
Dennis M. Nally  174,129,172  1,430,818  151,472  8,997,321
Lauren M. Tyler  175,361,050  203,108  147,304  8,997,321

 

Item 2 - Advisory Vote to Approve the Compensation of the Company’s Named Executive Officers.

 

The Company’s shareholders approved this item. The voting results were as follows:

 

For  Against  Abstentions  Broker Non-Votes
164,272,546  10,905,767  533,149  8,997,321

  

 

 

 

Item 3 - Ratification of Appointment of Ernst & Young LLP as the Company’s Independent Registered Public Accounting Firm for Fiscal Year 2024.

 

The Company’s shareholders approved this item. The voting results were as follows:

 

For  Against  Abstentions  Broker Non-Votes
170,700,405  13,876,371  132,007  N/A

 

Item 4 – Approval of an Amendment of the Company’s Certificate of Incorporation to Provide for the Exculpation of Officers as Permitted by Delaware Law.

 

The Company’s shareholders approved this item. The voting results were as follows:

 

For  Against  Abstentions  Broker Non-Votes
156,052,344  19,420,865  238,253  8,997,321

 

Item 5 – Approval of Miscellaneous Amendments to the Company’s Certificate of Incorporation.

 

The Company’s shareholders approved this item. The voting results were as follows:

 

For  Against  Abstentions  Broker Non-Votes
175,345,092  117,224  249,146  8,997,321

 

No item other than the five items addressed above and described in the Proxy Statement was submitted at the Annual Meeting for shareholder action.

 

The shareholder proposal as set forth in the Proxy Statement regarding the voting standard for the election of directors was not properly presented for a vote because the proponent failed to present the proposal personally or through a qualified representative at the Annual Meeting. If the shareholder proposal had been properly presented, the proposal would not have been approved by the shareholders, with the voting results as follows:

 

For  Against  Abstentions  Broker Non-Votes
1,283,645  173,604,022  823,795  8,997,321

 

Item 9.01 Financial Statements and Exhibits.

 

(d) Exhibits.

 

Exhibit
Number
 
  Description  
3.1   Amended and Restated Certificate of Incorporation of Cencora, Inc., effective March 14, 2024.
104   Cover Page Interactive Data File (formatted as inline XBRL)

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  Cencora, Inc.
     
March 15, 2024 By: /s/ Elizabeth S. Campbell
    Name: Elizabeth S. Campbell
    Title: Executive Vice President and Chief Legal Officer